Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
UBS
Healthtrust
Deloitte
Medtronic
Argus Health
Express Scripts
Covington

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022315

« Back to Dashboard

NDA 022315 describes OZURDEX, which is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are fifteen patents protecting this drug. Additional details are available on the OZURDEX profile page.

The generic ingredient in OZURDEX is dexamethasone. There are thirty-nine drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
Summary for 022315
Pharmacology for NDA: 022315
Medical Subject Heading (MeSH) Categories for 022315
Suppliers and Packaging for NDA: 022315
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OZURDEX dexamethasone IMPLANT;INTRAVITREAL 022315 NDA Allergan, Inc. 0023-3348 E 0023-3348-07
OZURDEX dexamethasone IMPLANT;INTRAVITREAL 022315 NDA Allergan, Inc. 0023-3348 E 0023-3348-08

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:IMPLANT;INTRAVITREALStrength0.7MG
Approval Date:Jun 17, 2009TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Oct 20, 2020Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF MACULAR EDEMA
Patent:➤ Try a Free TrialPatent Expiration:Oct 20, 2020Product Flag?YSubstance Flag?Delist Request?
Patented Use:TREATMENT OF UVEITIS
Patent:➤ Try a Free TrialPatent Expiration:Nov 1, 2023Product Flag?Substance Flag?Delist Request?
Patented Use:DELIVERING AN OCULAR IMPLANT AS DESCRIBED IN THE DOSAGE AND ADMINISTRATION SECTION OF THE APPROVED LABELING OF OZURDEX

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Moodys
Johnson and Johnson
Covington
Citi
Accenture
Baxter
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.